Pharma & Biotech

Shares of clinical-stage biopharmaceutical company Immuneering Corporation are posting significant gains today, advancing 2.46% to trade at $8.34. This upward...

While Precigen recently secured a $125 million credit facility and gained full FDA approval for its flagship product, AdenoVerse™ PRZIME™...

Danish pharmaceutical giant Novo Nordisk has unveiled a sweeping workforce reduction plan that will eliminate approximately 9,000 positions, representing about...

Telehealth innovator Hims & Hers Health is pursuing a significant expansion opportunity that could unlock substantial new revenue streams. Rather...

As its share price continues to struggle, Illumina is making a decisive strategic move by entering the human protein measurement...

Assembly Biosciences shares are experiencing a significant correction phase. The biotechnology stock has now recorded losses for three consecutive trading...

Cue Biopharma presents investors with a dramatic dichotomy. While market analysts project share price appreciation exceeding 400%, the company's own...

The obesity treatment market is becoming increasingly competitive as multiple pharmaceutical companies advance their GLP-1 receptor agonist candidates. Viking Therapeutics...

Phibro Animal Health Corporation continues to demonstrate remarkable market performance, driven by exceptional fiscal results and strategic expansion within the...

Despite showcasing its industry-critical role at two major healthcare conferences this week, Certara's stock continues to trade at depressed levels....